BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $8,540,000 | -74.7% | 133,690 | -57.6% | 0.10% | -69.6% |
| Q4 2021 | $33,808,000 | +87.7% | 315,639 | +80.2% | 0.34% | +61.2% |
| Q3 2021 | $18,008,000 | +66.2% | 175,159 | +42.2% | 0.21% | +48.6% |
| Q2 2021 | $10,836,000 | -15.1% | 123,198 | -6.1% | 0.14% | -23.4% |
| Q1 2021 | $12,756,000 | -10.3% | 131,194 | +3.5% | 0.19% | -18.3% |
| Q4 2020 | $14,214,000 | +16.8% | 126,744 | -3.5% | 0.23% | -8.0% |
| Q3 2020 | $12,173,000 | +108.8% | 131,320 | +75.7% | 0.25% | +76.1% |
| Q2 2020 | $5,829,000 | +130.4% | 74,734 | +72.7% | 0.14% | +67.1% |
| Q1 2020 | $2,530,000 | -47.6% | 43,266 | -28.3% | 0.08% | -33.6% |
| Q4 2019 | $4,831,000 | -11.9% | 60,303 | -19.2% | 0.13% | -28.1% |
| Q3 2019 | $5,483,000 | -49.0% | 74,635 | -34.5% | 0.18% | -47.2% |
| Q2 2019 | $10,742,000 | +4.6% | 113,874 | -11.3% | 0.34% | -12.7% |
| Q1 2019 | $10,273,000 | +903.2% | 128,331 | +575.6% | 0.39% | +777.3% |
| Q4 2018 | $1,024,000 | -31.0% | 18,995 | 0.0% | 0.04% | -4.3% |
| Q3 2018 | $1,483,000 | -83.1% | 18,995 | -86.2% | 0.05% | -84.5% |
| Q2 2018 | $8,766,000 | -67.7% | 138,093 | -53.4% | 0.30% | -69.2% |
| Q1 2018 | $27,170,000 | +28.2% | 296,289 | +5.4% | 0.96% | +19.4% |
| Q4 2017 | $21,195,000 | +63.8% | 281,060 | +51.3% | 0.80% | +59.5% |
| Q3 2017 | $12,940,000 | -54.9% | 185,735 | -67.2% | 0.50% | -52.3% |
| Q2 2017 | $28,719,000 | -19.5% | 566,777 | -36.4% | 1.06% | -13.6% |
| Q1 2017 | $35,659,000 | +19.7% | 891,691 | -16.0% | 1.22% | +16.0% |
| Q4 2016 | $29,779,000 | +10.1% | 1,061,625 | +16.6% | 1.05% | +15.2% |
| Q3 2016 | $27,045,000 | +75.7% | 910,621 | +19.8% | 0.91% | +66.5% |
| Q2 2016 | $15,396,000 | +28.9% | 760,303 | +14.9% | 0.55% | +41.9% |
| Q1 2016 | $11,944,000 | -33.3% | 661,717 | -2.7% | 0.39% | -35.9% |
| Q4 2015 | $17,915,000 | +43.0% | 680,160 | +15.9% | 0.60% | +33.6% |
| Q3 2015 | $12,526,000 | -6.9% | 586,959 | +15.6% | 0.45% | -2.8% |
| Q2 2015 | $13,452,000 | – | 507,827 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
| Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
| DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
| Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
| SIB LLC | 65,151 | $6,335,000 | 3.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
| Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
| Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
| Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
| Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |